麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Dec 21 2023

Full Issue

Research Roundup: HPV Vaccination; Paxlovid; Pneumonia; Noma

Each week, 麻豆女优 Health News compiles a selection of recently released health policy studies and briefs.

A research letter yesterday in JAMA Pediatrics study shows that children younger than 13 years still have significant gaps in human papillomavirus (HPV) vaccination coverage, despite the US Centers for Disease Control and Prevention's Advisory Committee for Immunization Practices recommendation for routine HPV vaccination for girls aged 11 to 12 years since 2006, and for boys since 2011. (Soucheray, 12/19)

Starting the antiviral drug nirmatrelvir-ritonavir (Paxlovid) 0 or 1 day after COVID-19 symptom onset halved 28-day all-cause death and hospitalization rates compared with waiting 2 or more days, University of Hong Kong researchers report in Nature Communications. (Van Beusekom, 12/19)

A meta-analysis today in JAMA Internal Medicine suggests that daily tooth brushing in hospitalized patients lowers the risk of hospital-onset pneumonia. The effect was strongest in patients who were receiving mechanical ventilation. (Soucheray, 12/18)

The World Health Organization (WHO) announced late last week that the gangrenous disease noma has been added to its official list of neglected tropical diseases (NTDs). Also known as gangrenous stomatitis or cancrum oris, noma is a rapidly progressive bacterial infection of the face and mouth. It begins as inflammation of the gums, and, if not treated early with antibiotics, spreads quickly to destroy facial tissue and bone, frequently leading to death or severe disfigurement. Diagnosis and treatment in the early stages of the infection can lead to proper wound healing. (Dall, 12/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优